These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1331252)

  • 1. Aging and reactivation of latent murine cytomegalovirus.
    Schmader KE; Rahija R; Porter KR; Daley G; Hamilton JD
    J Infect Dis; 1992 Dec; 166(6):1403-7. PubMed ID: 1331252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine cytomegalovirus gene amplification and culture after submaxillary salivary gland biopsy.
    Schmader KE; Rahija RJ; Porter KR; Hamilton JD
    Lab Anim Sci; 1991 Oct; 41(5):396-400. PubMed ID: 1666135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide increases the amount of murine cytomegalovirus-DNA in mice latently infected with the virus.
    Okada K; Tanaka K; Noda S; Okazaki M; Koga Y
    Arch Virol; 1999; 144(12):2273-90. PubMed ID: 10664384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus.
    Koffron AJ; Mueller KH; Kaufman DB; Stuart FP; Patterson B; Abecassis MI
    Scand J Infect Dis Suppl; 1995; 99():61-2. PubMed ID: 8668944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine cytomegalovirus ocular infection in immunocompetent and cyclophosphamide-treated mice. Potentiation of ocular infection by cyclophosphamide.
    Bale JF; O'Neil ME; Folberg R
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1749-56. PubMed ID: 1851731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections.
    Okada M; Minamishima Y
    Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular reactivation of MCMV after immunosuppression of latently infected BALB/c mice.
    Zhang M; Xin H; Duan Y; Atherton SS
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):252-8. PubMed ID: 15623781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR.
    Wheat RL; Clark PY; Brown MG
    J Virol Methods; 2003 Sep; 112(1-2):107-13. PubMed ID: 12951218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent murine cytomegalovirus DNA in splenic stromal cells of mice.
    Pomeroy C; Hilleren PJ; Jordan MC
    J Virol; 1991 Jun; 65(6):3330-4. PubMed ID: 1851880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
    Cook CH; Zhang Y; Sedmak DD; Martin LC; Jewell S; Ferguson RM
    Crit Care Med; 2006 Mar; 34(3):842-9. PubMed ID: 16521279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo reactivation of latent murine cytomegalovirus in the eye by immunosuppressive treatment.
    Rabinovitch T; Oh JO; Minasi P
    Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):657-63. PubMed ID: 2159448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression induces transcription of murine cytomegalovirus glycoprotein H in the eye and at non-ocular sites.
    Duan Y; Atherton SS
    Arch Virol; 1996; 141(3-4):411-23. PubMed ID: 8645084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
    Yuhasz SA; Dissette VB; Cook ML; Stevens JG
    Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency.
    Brautigam AR; Dutko FJ; Olding LB; Oldstone MB
    J Gen Virol; 1979 Aug; 44(2):349-59. PubMed ID: 230287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus.
    Tanaka K; Koga Y; Lu YY; Zhang XY; Wang Y; Kimura G; Nomoto K
    J Clin Invest; 1994 Sep; 94(3):1019-25. PubMed ID: 8083343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice.
    Wilson EJ; Medearis DN; Hansen LA; Rubin RH
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1017-20. PubMed ID: 2821884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of Toxoplasma gondii by cytomegalovirus disease in mice: antimicrobial activities of macrophages.
    Pomeroy C; Kline S; Jordan MC; Filice GA
    J Infect Dis; 1989 Aug; 160(2):305-11. PubMed ID: 2547877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.